Challenges of Identifying and Reducing Sepsis Mortality – Episode 2
In episode 2 of The Michael Rothman Podcast, Michael Rothman examines the difficulties of identifying and reducing sepsis mortality, focusing on inconsistent definitions and unreliable screening protocols. He argues that current sepsis-specific initiatives produce high false-positive rates and have not meaningfully lowered mortality. The episode questions whether narrowly focused sepsis programs are the most effective approach to improving patient outcomes.
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Promoted content from The Michael Rothman Podcast on MarketScale.
Key takeaways
Varying definitions of sepsis create significant challenges for consistent clinical identification and management.
Current sepsis screening protocols frequently generate high false-positive rates, limiting their clinical utility.
Sepsis-specific mortality reduction initiatives may be misaligned; broader patient monitoring approaches could be more effective.
Get featured
Want MarketScale to feature Healthcare?
Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.
Michael Rothman explores the complexities of sepsis identification and management, highlighting the challenges posed by varying definitions and clinical pathways. He discusses the ineffectiveness of current sepsis screening protocols, which often yield high false-positive rates and fail to reduce mortality meaningfully. The episode concludes by questioning the focus on sepsis-specific initiatives and suggesting that more effective strategies are needed for improving patient outcomes.
Part of this channel
The Michael Rothman Podcast
Data science meets clinical medicine with Dr. Michael Rothman.
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.
Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.
About the author
